Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01874184 · ClinicalTrials.gov registry record · NA

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT01874184: Completed NA study, sponsored by University of Washington.

NCT01874184 is a NA study that has completed, run by University of Washington. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01874184, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

This randomized clinical trial studies a group-based lifestyle intervention or usual care in measuring biomarker levels in participants at high risk for breast cancer. Studying the effects that changes to daily eating and exercise habits can have on the body's hormone levels and the body's ability to activate proteins may help doctors identify interventions for individuals at high risk for breast cancer.

Primary Outcome

Descriptive statistics will be calculated. The percentage of women meeting the study's eligibility criteria, percentage of those who agree to participate, and the percentage of those who complete the study will be stratified by intervention group. This analysis will summarize data collected from the participants' into themes.

Interventions

  • OTHER laboratory biomarker analysis
  • OTHER questionnaire administration
  • BEHAVIORAL exercise intervention
  • OTHER counseling intervention
  • BEHAVIORAL behavioral dietary intervention

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2013-10
Phase NA
University of Washington

1,048 total trials

What the finished NCT01874184 record still lists

NCT01874184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.

NCT01874184 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01874184 about?

NCT01874184 is a clinical study titled "Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer". This randomized clinical trial studies a group-based lifestyle intervention or usual care in measuring biomarker levels in participants at high risk for breast cancer. Studying the effects that changes to daily eating and exercise habits can have on the body's hormone levels and the body's ability t...

What is the current status of trial NCT01874184?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2013-10.

What interventions are being tested in trial NCT01874184?

The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), exercise intervention (BEHAVIORAL), counseling intervention (OTHER), behavioral dietary intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01874184?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01874184's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01874184, the US trial registry maintained by the National Library of Medicine. NCT01874184 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.